The AHA supports the Centers for Medicare & Medicaid Services’ proposal to delay the January 2023 start of the Radiation Oncology Model to a date determined through future rulemaking, the association told the agency today.

Commenting on the proposed rule for the model, AHA said it “strongly supports CMS’ efforts to transform the delivery of cancer care. We also support the original intent of the RO Model, which was to protect access to care by ensuring fair, predictable payment for radiation oncologists. However, this important goal of the original RO Model has been marred by the incorporation of significant payment cuts and substantial administrative burdens for those participating in this mandatory model.”

AHA urged the agency to consider incorporating its previously recommended changes if the model advances in the future, including “adopting a risk versus reward equation that is much more appropriately balanced.”
 

Related News Articles

Headline
The White House yesterday launched TrumpRx, the direct-to-consumer platform that will serve as a hub to direct cash-paying consumers to drug manufacturers…
Headline
The Department of Health and Human Services Feb. 5 in a court filing said it would scrap its current 340B Rebate Model Pilot Program and potentially restart…
Headline
The AHA Feb. 5 announced WVU Medicine Potomac Valley Hospital in Keyser, W.Va., as the 2026 recipient of the new Rural Hospital Excellence in Innovation Award…
Headline
A new AHA blog published Feb. 3 discusses how the 340B Drug Pricing Program serves as an effective solution to some of the nation’s most persistent and…
Blog
Public
Many Americans may be unaware that the services they rely on every day through their local hospital are supported by a program called the 340B Drug Pricing…
Headline
The Centers for Medicare & Medicaid Services Feb. 2 updated guidance originally issued in September on a budget reconciliation bill …